ACM

Aquilo Capital Management Portfolio holdings

AUM $37.1M
This Quarter Return
+4.58%
1 Year Return
-36.49%
3 Year Return
+1.32%
5 Year Return
+39.69%
10 Year Return
–
AUM
$133M
AUM Growth
+$133M
Cap. Flow
+$15M
Cap. Flow %
11.24%
Top 10 Hldgs %
99.82%
Holding
15
New
1
Increased
6
Reduced
3
Closed
3

Top Buys

1
SYBX icon
Synlogic
SYBX
$9.82M
2
XENE icon
Xenon Pharmaceuticals
XENE
$7.83M
3
FATE icon
Fate Therapeutics
FATE
$6.59M
4
SPRO icon
Spero Therapeutics
SPRO
$4.03M
5
MRUS icon
Merus
MRUS
$884K

Top Sells

1
AUTL
Autolus Therapeutics
AUTL
$4.02M
2
GLPG icon
Galapagos
GLPG
$3.9M
3
CLLS
Cellectis
CLLS
$3.36M
4
LOXO
Loxo Oncology, Inc
LOXO
$2.99M
5
FPRX
Five Prime Therapeutics, Inc.
FPRX
$1.03M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MRUS icon
1
Merus
MRUS
$4.98B
$25.6M 10.7%
1,295,713
+44,799
+4% +$884K
LOXO
2
DELISTED
Loxo Oncology, Inc
LOXO
$18.7M 7.82%
109,312
-17,500
-14% -$2.99M
FATE icon
3
Fate Therapeutics
FATE
$120M
$16M 6.71%
984,596
+404,367
+70% +$6.59M
KDNY
4
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$15.5M 6.48%
2,105,282
+97,383
+5% +$716K
SYBX icon
5
Synlogic
SYBX
$17M
$14.2M 5.94%
998,034
+691,240
+225% +$9.82M
CTMX icon
6
CytomX Therapeutics
CTMX
$336M
$12.5M 5.22%
674,763
+25,000
+4% +$462K
PVLA
7
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$11.1M 4.63%
1,975,098
– –
SPRO icon
8
Spero Therapeutics
SPRO
$116M
$8.41M 3.52%
799,691
+383,000
+92% +$4.03M
XENE icon
9
Xenon Pharmaceuticals
XENE
$2.98B
$7.83M 3.27%
+592,802
New +$7.83M
GLPG icon
10
Galapagos
GLPG
$2.07B
$3.52M 1.47%
31,320
-34,730
-53% -$3.9M
MOR
11
DELISTED
MorphoSys AG American Depositary Shares
MOR
$243K 0.1%
9,087
-913
-9% -$24.4K
AUTL
12
Autolus Therapeutics
AUTL
$399M
– –
-150,000
Closed -$4.02M
CLLS
13
Cellectis
CLLS
$258M
– –
-118,873
Closed -$3.36M
XBI icon
14
SPDR S&P Biotech ETF
XBI
$5.07B
– –
0
– –
FPRX
15
DELISTED
Five Prime Therapeutics, Inc.
FPRX
– –
-64,881
Closed -$1.03M